ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,310.40
-0.20%
S&P ASX All Technology
3,765.60
-0.15%
Brent Oil
80.705
0.24%
US Dollar vs AUD
1.61233
0.13%
Bitcoin
101,829.07
1.82%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Vivoryon Therapeut (VVY) Share Price

Vivoryon Therapeut

Vivoryon Therapeut (VVY)

EU
2.01
0.005
( 0.25% )
Updated: 20:41:26
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
2.01
Bid
1.996
Offer
2.01
Volume
2,968
2.00 Day's Range 2.01
0.41 52 Week Range 9.93
Market Cap
-
Previous Close
2.005
Open
2.01
Last Trade
45
@
2.01
Last Trade Time
20:25:42
Financial Volume
-
VWAP
-
Average Volume (3m)
181,338
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
-3.62M
Net Profit
-28.34M

About Vivoryon Therapeut

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
-
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker VVY. The last closing price for Vivoryon Therapeut was 2.01 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0.41 € to 9.93 €.

Vivoryon Therapeut currently has 0 shares in issue.

Ask ADVFN Intelligence (AI)

VVY Latest News

More News

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function Vivoryon Therapeutics N.V. Presents Topline Phase...

09 December 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress...

04 December 2024
UK Regulatory

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of...

26 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon...

12 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event Halle (Saale) / Munich, Germany, October 1, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...

01 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Vivoryon Therapeutics N.V...

12 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and...

06 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024 Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial...

05 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in...

18 July 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Halle (Saale) / Munich, Germany, July 9, 2024 - Vivoryon Therapeutics N.V. (Euronext...

09 July 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.035-1.711491442542.0452.251.931324022.022168DE
40.073.608247422681.942.251.9121171462.04709252DE
12-0.39-16.252.42.71.671813382.17767997DE
26-0.18-8.219178082192.192.9951.672290262.30359028DE
52-5.75-74.09793814437.769.930.415614481.97902936DE
156-14.99-88.17647058821719.560.412296453.703432DE
260-5.33-72.61580381477.3423.250.411745155.03071958DE

VVY - Frequently Asked Questions (FAQ)

What is the current Vivoryon Therapeut share price?
The current share price of Vivoryon Therapeut is 2.01 €
What is the 1 year trading range for Vivoryon Therapeut share price?
Vivoryon Therapeut has traded in the range of 0.41 € to 9.93 € during the past year
What is the reporting currency for Vivoryon Therapeut?
Vivoryon Therapeut reports financial results in EUR
What is the latest annual turnover for Vivoryon Therapeut?
The latest annual turnover of Vivoryon Therapeut is EUR -3.62M
What is the latest annual profit for Vivoryon Therapeut?
The latest annual profit of Vivoryon Therapeut is EUR -28.34M
What is the registered address of Vivoryon Therapeut?
The registered address for Vivoryon Therapeut is WEINBERGWEG 22, HALLE, 06120
What is the Vivoryon Therapeut website address?
The website address for Vivoryon Therapeut is www.vivoryon.com
Which industry sector does Vivoryon Therapeut operate in?
Vivoryon Therapeut operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DRVDSDrone Volt
0.0036 €
(3,500.00%)
170.38k
GTRDSGroupe Tera DS
0.01 €
(53.85%)
112
DMSBSDiagnostic Medical Systems
0.0055 €
(37.50%)
35.78k
FIPPFipp
0.14 €
(22.81%)
1,000
NICBSNicox SA
0.021 €
(19.32%)
270
ALVERVergnet
0.0016 €
(-15.79%)
57.83M
ALBOOBOOSTHEAT
0.0632 €
(-15.51%)
26.07k
NYRNyrstar NV
0.0726 €
(-14.59%)
356.89k
ALAMAAMA Corporation PLC
0.1605 €
(-13.94%)
16.72k
ALSAFSAFE
0.032 €
(-9.60%)
336.06k
ATOAtos SE
0.0021 €
(0.00%)
302.6M
ALVERVergnet
0.0016 €
(-15.79%)
57.83M
BCPBanco Comercial Portugues SA
0.4988 €
(0.79%)
15.68M
EDPEDP SA
3.179 €
(2.19%)
2.83M
ALCYBCybergun
0.0001 €
(0.00%)
2.22M

Discussion

View Full Feed
TexasMarvL TexasMarvL 4 minutes ago
Found this article about silver and nuclear. 

https://www.globenewswire.com/news-release/2018/07/05/1533658/0/en/Over-1-5-Billion-Ounces-of-Silver-Forecast-to-be-Consumed-in-Crucial-Green-Technologies-Through-2030.html#:~:text=An%20often%2Doverlooked%20application%20for,produce%20the%
FFMGF
Golden Cross Golden Cross 6 minutes ago
GRLF getting things done as they have said they would do
GRLF
RichieBoy RichieBoy 9 minutes ago
Projection!

Yes good for them making 4M

Nobody knows what they made yet except insiders. Frankly that sounds very conservative if I'm being honest. Say Risk, if Steve Balmer and Mike Balkin got together and had a baby... Do you think they'd name it ED?

AFFU
TrendTrade2016 TrendTrade2016 11 minutes ago
I WILL GIVE A TIDBIT OF INSIGHT...008 IS NEXT...WHY...NO CLOWNS HERE KNOW THE REASON WHY .008 IS NEXT..AND WHAT THAT MAGNET REPRESENTS...REMEMBER THE 20TH AS MENTIONED...HEHEHEHE..WATCH AND LEARN...YOU ARE ABOUT TO GET SCHOOLED!!!
GVSI
Bull_Dolphin Bull_Dolphin 12 minutes ago
Here's the local rag's write up on Ashley:

Florida Attorney General Ashley Moody is chosen to fill Marco Rubio's open Senate seat
Under Florida law, it's up to the Republican governor to pick Rubio's replacement after President-elect Donald Trump picked the three-term senator t
Idiot Mayor Idiot Mayor 13 minutes ago
Wrong update posted? Ooops? You made some illegal statements and had to edit them real quick or what? Guess what - you didn’t get them all. Your handling of the English language is truly pathetic, Poo. The person who hired you to write these things is a complete and total idiot.

You
DBMM
Sheepdog Sheepdog 15 minutes ago
Those who bought in July of 2018 are down by 99.97%.

Speaking of that, whatever happened to Sprycel?
GCAN
eagle8 eagle8 15 minutes ago
Gregory Zivic, MD
@metacollectiveG
·
13h
$NWBO I think we’re really close to a whole lot of incredible things occurring. LP is shrewd and quiet. Licensing is like owning great properties with top notch renters as your equity grows in leaps
NWBO
TrendTrade2016 TrendTrade2016 15 minutes ago
OH WHERE OH WHERE IS THE TOP...NOBODY KNOWS BUT ME...THE CHART IS TELLING ME EVERYTHING I NEED TO SEE ...A PIC IS 1000 WORKS AND PUMPING CLOWNS GUESSING IS TOO FUNNY...EVEN G-MAN IS GIGLING ON THE SIDE LINES....HIS LAST DANCE!!!
GVSI
SkeBallLarry SkeBallLarry 17 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 18 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
Investor082 Investor082 19 minutes ago
Don't fall for these gaslighting tricks from Flip! There is nothing meaningful to hide. The reality is big pharma is not going to pay NWBO to license the technology. Otherwise there is no point wasting time and endlessly diluting shares at depressed prices. NWBO wouldn’t have front run big pharma by
NWBO
joev2 joev2 19 minutes ago
One thing you can always count on by leadership and that is NOT being informed properly and in a timely manner as to what is ACTUALLY happening.
But the US numbers are not unusual for this time of year and doctors have reassured the public that hMPV is mild for most.
SINT
SkeBallLarry SkeBallLarry 19 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
TrendTrade2016 TrendTrade2016 20 minutes ago
THE CLOWN SHOW HAS STARTED AND THE MAGGOTS ARE COMING OUT OF THE WOODWORK..BAGHOLDERS DREAMING OF 5C 10C AND THIS IS JUST THE BEGINNING....LOL...LOST LITTLE DONKEYS!!!
GVSI
marcis marcis 21 minutes ago
Good morning $RDAR I slept good last night.

I can see others spent the whole night, digging for anything they can find. LOL

Too soon to be debunked again 🏅🏆

BTW Buenos Aries is two hours ahead of EST NYC
RDA
RichieBoy RichieBoy 23 minutes ago
Best of luck with FDCT

THE ONLY possible downside I can see here is after 3 long years of waiting. You get caught on the wrong side of the official calendar date for verified ownership to the new share structure. Perhaps your sixth sense will see you through on that score. Hopefully y
FDCT
Bull_Dolphin Bull_Dolphin 24 minutes ago
They were taken off the endangered list a good while back. They are slow moving and hard to see so they do sometimes get hit by boats. In areas where they aggregate the Fish and Wildlife Commission (FWC) has established slow speed zones to lessen collisions. Still, a number of the ones I see have
Sheepdog Sheepdog 24 minutes ago
Brain? Doesn't appear so. It doesn't take brains to scam people out of their money and justify it by saying they deserved it for investing in OTC stocks.
GCAN
SkeBallLarry SkeBallLarry 25 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 27 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
elks elks 28 minutes ago
Haha up we go We all buy we all fly gvsi.
GVSI
navycmdr navycmdr 28 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/1/17/neysmScreenshot_20250117_011619_X.jpg
FNMA
WolfofMia WolfofMia 29 minutes ago
Go to sleep! Get some rest.
AVXL
Stino2 Stino2 30 minutes ago
Why does this stock keeps going down?
TNXP

Your Recent History

EU
VVY
Vivoryon Therapeut
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads